Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Heart failure is associated with depletion of core intestinal microbiota.

Luedde M, Winkler T, Heinsen FA, Rühlemann MC, Spehlmann ME, Bajrovic A, Lieb W, Franke A, Ott SJ, Frey N.

ESC Heart Fail. 2017 Aug;4(3):282-290. doi: 10.1002/ehf2.12155. Epub 2017 Apr 21.

2.

Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.

Ott SJ, Waetzig GH, Rehman A, Moltzau-Anderson J, Bharti R, Grasis JA, Cassidy L, Tholey A, Fickenscher H, Seegert D, Rosenstiel P, Schreiber S.

Gastroenterology. 2017 Mar;152(4):799-811.e7. doi: 10.1053/j.gastro.2016.11.010. Epub 2016 Nov 17.

3.

Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin.

Heinsen FA, Knecht H, Neulinger SC, Schmitz RA, Knecht C, Kühbacher T, Rosenstiel PC, Schreiber S, Friedrichs AK, Ott SJ.

Gut Microbes. 2015 Jul 4;6(4):243-54. doi: 10.1080/19490976.2015.1062959.

4.

Structural and functional changes in the gut microbiota associated to Clostridium difficile infection.

Pérez-Cobas AE, Artacho A, Ott SJ, Moya A, Gosalbes MJ, Latorre A.

Front Microbiol. 2014 Jul 4;5:335. doi: 10.3389/fmicb.2014.00335. eCollection 2014.

5.

Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.

Knecht H, Neulinger SC, Heinsen FA, Knecht C, Schilhabel A, Schmitz RA, Zimmermann A, dos Santos VM, Ferrer M, Rosenstiel PC, Schreiber S, Friedrichs AK, Ott SJ.

PLoS One. 2014 Feb 28;9(2):e89417. doi: 10.1371/journal.pone.0089417. eCollection 2014.

6.

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach.

Ferrer M, Martins dos Santos VA, Ott SJ, Moya A.

Gut Microbes. 2014 Jan-Feb;5(1):64-70. doi: 10.4161/gmic.27128. Epub 2013 Dec 13.

7.

Characteristic changes in microbial community composition and expression of innate immune genes in acute appendicitis.

Arlt A, Bharti R, Ilves I, Häsler R, Miettinen P, Paajanen H, Brunke G, Ellrichmann M, Rehman A, Hauser C, Egberts JH, Ott SJ, Schreiber S, Rosenstiel P, Herzig KH.

Innate Immun. 2015 Jan;21(1):30-41. doi: 10.1177/1753425913515033. Epub 2013 Dec 11.

PMID:
24336024
8.

Differential effects of antibiotic therapy on the structure and function of human gut microbiota.

Pérez-Cobas AE, Artacho A, Knecht H, Ferrús ML, Friedrichs A, Ott SJ, Moya A, Latorre A, Gosalbes MJ.

PLoS One. 2013 Nov 25;8(11):e80201. doi: 10.1371/journal.pone.0080201. eCollection 2013.

9.

Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity.

Hernández E, Bargiela R, Diez MS, Friedrichs A, Pérez-Cobas AE, Gosalbes MJ, Knecht H, Martínez-Martínez M, Seifert J, von Bergen M, Artacho A, Ruiz A, Campoy C, Latorre A, Ott SJ, Moya A, Suárez A, Martins dos Santos VA, Ferrer M.

Gut Microbes. 2013 Jul-Aug;4(4):306-15. doi: 10.4161/gmic.25321. Epub 2013 Jun 12.

10.

Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans.

Biedermann L, Zeitz J, Mwinyi J, Sutter-Minder E, Rehman A, Ott SJ, Steurer-Stey C, Frei A, Frei P, Scharl M, Loessner MJ, Vavricka SR, Fried M, Schreiber S, Schuppler M, Rogler G.

PLoS One. 2013;8(3):e59260. doi: 10.1371/journal.pone.0059260. Epub 2013 Mar 14.

11.

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach.

Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, Otto W, Rojo D, Bargiela R, von Bergen M, Neulinger SC, Däumer C, Heinsen FA, Latorre A, Barbas C, Seifert J, dos Santos VM, Ott SJ, Ferrer M, Moya A.

Gut. 2013 Nov;62(11):1591-601. doi: 10.1136/gutjnl-2012-303184. Epub 2012 Dec 12.

12.

Microbial community composition on modified dental implant surfaces: an in vivo study.

Rehman A, Hu J, Ott SJ, Grössner-Schreiber B.

Int J Oral Maxillofac Implants. 2012 Jul-Aug;27(4):811-9.

PMID:
22848882
13.

Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine.

Rehman A, Heinsen FA, Koenen ME, Venema K, Knecht H, Hellmig S, Schreiber S, Ott SJ.

BMC Microbiol. 2012 Mar 27;12:47. doi: 10.1186/1471-2180-12-47.

14.

Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype.

Rausch P, Rehman A, Künzel S, Häsler R, Ott SJ, Schreiber S, Rosenstiel P, Franke A, Baines JF.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19030-5. doi: 10.1073/pnas.1106408108. Epub 2011 Nov 8.

15.

[Genetic susceptibility to infections].

Ott SJ, Schreiber S.

Internist (Berl). 2011 Sep;52(9):1053-4, 1056-8, 1060. doi: 10.1007/s00108-011-2858-8. Review. German.

PMID:
21842176
16.

Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients.

Rehman A, Lepage P, Nolte A, Hellmig S, Schreiber S, Ott SJ.

J Med Microbiol. 2010 Sep;59(Pt 9):1114-22. doi: 10.1099/jmm.0.021170-0. Epub 2010 Jun 3.

PMID:
20522625
17.

Modified implant surfaces show different biofilm compositions under in vivo conditions.

Grössner-Schreiber B, Teichmann J, Hannig M, Dörfer C, Wenderoth DF, Ott SJ.

Clin Oral Implants Res. 2009 Aug;20(8):817-26. doi: 10.1111/j.1600-0501.2009.01729.x. Epub 2009 Jun 7.

PMID:
19508342
18.

Yersinia enterocolitica: another factor in the pathogenesis of chronic urticaria?

Hellmig S, Troch K, Ott SJ, Fölsch UR, Schwarz T.

Clin Exp Dermatol. 2009 Oct;34(7):e292. doi: 10.1111/j.1365-2230.2009.03226.x. Epub 2009 May 18. No abstract available.

PMID:
19456795
19.

Germline variations of the MALT1 gene as risk factors in the development of primary gastric B-cell lymphoma.

Hellmig S, Bartscht T, Fischbach W, Ott SJ, Rosenstiel P, Klapper W, Fölsch UR, Schreiber S.

Eur J Cancer. 2009 Jul;45(10):1865-70. doi: 10.1016/j.ejca.2009.03.010. Epub 2009 Apr 24.

PMID:
19394813
20.

Role of Helicobacter pylori Infection in the treatment and outcome of chronic urticaria.

Hellmig S, Troch K, Ott SJ, Schwarz T, Fölsch UR.

Helicobacter. 2008 Oct;13(5):341-5. doi: 10.1111/j.1523-5378.2008.00620.x.

PMID:
19250508
21.

Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease.

Kuehbacher T, Rehman A, Lepage P, Hellmig S, Fölsch UR, Schreiber S, Ott SJ.

J Med Microbiol. 2008 Dec;57(Pt 12):1569-76. doi: 10.1099/jmm.0.47719-0.

PMID:
19018031
22.

Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse.

Ott SJ, Plamondon S, Hart A, Begun A, Rehman A, Kamm MA, Schreiber S.

J Clin Microbiol. 2008 Oct;46(10):3510-3. doi: 10.1128/JCM.01512-08. Epub 2008 Aug 13.

23.

Fungi and inflammatory bowel diseases: Alterations of composition and diversity.

Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S.

Scand J Gastroenterol. 2008;43(7):831-41. doi: 10.1080/00365520801935434.

PMID:
18584522
24.

Fungal rDNA signatures in coronary atherosclerotic plaques.

Ott SJ, El Mokhtari NE, Rehman A, Rosenstiel P, Hellmig S, Kühbacher T, Lins M, Simon R, Schreiber S.

Environ Microbiol. 2007 Dec;9(12):3035-45.

PMID:
17991032
25.

Role of NOD2/CARD15 in coronary heart disease.

El Mokhtari NE, Ott SJ, Nebel A, Schäfer A, Rosenstiel P, Förster M, Nothnagel M, Simon R, Schreiber S.

BMC Genet. 2007 Nov 2;8:76.

26.

A functional variant in the CARD4 gene and risk of premature coronary heart disease.

El Mokhtari NE, Ott SJ, Nebel A, Simon R, Schreiber S.

Int J Immunogenet. 2006 Aug;33(4):307-11.

PMID:
16893397
27.

Reduced microbial diversity in inflammatory bowel diseases.

Ott SJ, Schreiber S.

Gut. 2006 Aug;55(8):1207. No abstract available.

28.

Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy.

Ochsenkühn T, Tillack C, Stepp H, Diebold J, Ott SJ, Baumgartner R, Brand S, Göke B, Sackmann M.

Endoscopy. 2006 May;38(5):477-82.

PMID:
16767582
29.

Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease.

Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kühbacher T, Nikolaus S, Namsolleck P, Blaut M, Hampe J, Sahly H, Reinecke A, Haake N, Günther R, Krüger D, Lins M, Herrmann G, Fölsch UR, Simon R, Schreiber S.

Circulation. 2006 Feb 21;113(7):929-37.

PMID:
16490835
30.

Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.

Kühbacher T, Ott SJ, Helwig U, Mimura T, Rizzello F, Kleessen B, Gionchetti P, Blaut M, Campieri M, Fölsch UR, Kamm MA, Schreiber S.

Gut. 2006 Jun;55(6):833-41. Epub 2006 Jan 9.

31.

In vitro alterations of intestinal bacterial microbiota in fecal samples during storage.

Ott SJ, Musfeldt M, Timmis KN, Hampe J, Wenderoth DF, Schreiber S.

Diagn Microbiol Infect Dis. 2004 Dec;50(4):237-45.

PMID:
15582296
33.

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S.

Gut. 2004 May;53(5):685-93.

34.

Intestinal obstruction after ingestion of a beer-filled condom at the Munich Octoberfest.

Ott SJ, Helmberger T, Beuers U.

Am J Gastroenterol. 2003 Feb;98(2):512-3. No abstract available.

PMID:
12591087
35.

Liver failure in adult Still's disease during corticosteroid treatment.

Ott SJ, Baron A, Berghaus T, Lamerz R, Beuers U.

Eur J Gastroenterol Hepatol. 2003 Jan;15(1):87-90.

PMID:
12544700

Supplemental Content

Support Center